Atossa Therapeutics, Inc. (ATOS)

4.21 -0.21 (-4.75%) USD  |  NASDAQ  |  Feb 20, 16:00
4.14 -0.07 (-1.66%) After-Hours: 20:00
More

Atossa Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for ATOS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Celldex Therapeutics, Inc. Upgrade
Plus Therapeutics, Inc. Upgrade
Abeona Therapeutics, Inc. Upgrade
Cell Source, Inc. --
Kiora Pharmaceuticals, Inc. Upgrade